Skip to content

Puma Biotechnology

US · PBYI #3745 by market cap
9.60 -0.22 -2.19%
Live - 5344 symbols - heartbeat 275s ago · 2026-10-08 09:58
Pre-market 9.68 -1.33%
After-hours 9.81 0.00%
Market cap
495.29M
P/B
3.57
EPS
0.61
Reader sentiment Are you bullish or bearish on PBYI?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $5
    Market Newswire · 2025/11/8
  • Rating change
    HC Wainwright & Co. : The Puma Biotechnology (PBYI.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.
    Zhitong Finance · 2024/5/20
  • Rating change
    H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI)
    TipRanks · 2023/2/1
  • Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ...
    Yahoo Finance · 2025/11/7
  • Rating change
    H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI)
    TipRanks · 2023/6/5
  • Rating change
    TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $4
    Market Newswire · 2025/8/8
  • Earnings Call Summary | Puma Biotechnology(PBYI.US) Q4 2025 Earnings Conference
    Market Newswire · 2026/2/27
  • Rating change
    TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Raises Target Price to $5
    Market Newswire · 2025/11/7
  • Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
    Yahoo Finance · 2026/2/27
  • Rating change
    H.C. Wainwright Sticks to Its Buy Rating for Puma Biotechnology (PBYI)
    TipRanks · 2022/12/9
  • Barclays Maintains Puma Biotechnology(PBYI.US) With Sell Rating, Maintains Target Price $2
    Market Newswire · 2025/11/7
  • Rating change
    H.C. Wainwright Maintains Puma Biotechnology(PBYI.US) With Buy Rating, Maintains Target Price $7
    Market Newswire · 2025/2/28

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 09:58:52 · For reference only, not investment advice and not tailored to your situation.